Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZW) Receivables (2021 - 2025)

Core Scientific (CORZW) has disclosed Receivables for 5 consecutive years, with $1.0 million as the latest value for Q1 2025.

  • Quarterly Receivables fell 8.04% to $1.0 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Mar 2025, down 8.04% year-over-year, with the annual reading at $1.0 million for FY2024, 2.4% up from the prior year.
  • Receivables hit $1.0 million in Q1 2025 for Core Scientific, down from $1.0 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $6.2 million in Q3 2024 to a low of $23000.0 in Q4 2022.
  • Historically, Receivables has averaged $1.9 million across 5 years, with a median of $1.1 million in 2023.
  • Biggest five-year swings in Receivables: crashed 98.63% in 2022 and later surged 4252.17% in 2023.
  • Year by year, Receivables stood at $1.7 million in 2021, then plummeted by 98.63% to $23000.0 in 2022, then soared by 4252.17% to $1.0 million in 2023, then rose by 2.4% to $1.0 million in 2024, then dropped by 0.68% to $1.0 million in 2025.
  • Business Quant data shows Receivables for CORZW at $1.0 million in Q1 2025, $1.0 million in Q4 2024, and $6.2 million in Q3 2024.